(4) National Institute of Arthritis and Musculoskeletal and Skin Diseases (osteoporosis, autoimmune diseases) and more. The fact that women's health cuts across all or almost all institutes and centers is one of the reasons NIH has a cross-cutting Office rather than a home in one institute. 5/11

Show Post

development of our platform and pipeline. In addition, we are actively pursuing inbound partnership and licensing opportunities for “Loom” across multiple verticals, with the goal of generating non-dilutive revenue to help fund and accelerate our core therapeutic discovery programs.

Show Post

novel microbial natural products against human therapeutic targets. Based in Chicago, we combine computational discovery with in-house wet-lab validation to move promising biology from prediction to drug lead. We are seeking investors, strategic partners, and collaborators to accelerate...

Show Post

Evoquant is an NIH SBIR-funded, AI/ML-powered drug discovery company using big data to unlock nature’s vast, largely unexplored chemical diversity. Evoquant’s “Loom” and “BioPredictor” platforms use AI/ML and large-scale biological data to systematically identify...

Show Post

We are thrilled to connect with fellow innovators, industry leaders, and ecosystem partners shaping the future of healthcare and life sciences.

Show Post